Potent and selective isophthalamide S(2) hydroxyethylamine inhibitors of BACE1.
Kortum, S.W., Benson, T.E., Bienkowski, M.J., Emmons, T.L., Prince, D.B., Paddock, D.J., Tomasselli, A.G., Moon, J.B., Laborde, A., Tenbrink, R.E.(2007) Bioorg Med Chem Lett 17: 3378-3383
- PubMed: 17434734 
- DOI: https://doi.org/10.1016/j.bmcl.2007.03.096
- Primary Citation of Related Structures:  
2P83 - PubMed Abstract: 
The design and synthesis of a novel series of potent BACE1 hydroxyethylamine inhibitors. These inhibitors feature hydrogen bonding substituents at the C-5 position of the isophthalamide ring with improved selectivity over cathepsin D.
Organizational Affiliation: 
Pfizer Global Research and Development, Pfizer Inc., St. Louis Laboratories, 700 Chesterfield Parkway West, Chesterfield, MO 63017, USA. steve.kortum@pfizer.com